Blogs
Healthcare and Medtech Research Reports
Notizia - Recent Pharma, Healthcare and Biotech Happenings
Keytruda wins FDA nod for treating Kidney Cancer Merck’s Keytruda has recently got the U.S. FDA approval to be administered for Kidney Cancer. The drug Keytruda was approved in combination with Pfizer’s Inlyta for the treatment of advanced renal carcinoma. This therapy could prove to be serious for competition Bristol-Myers Squibb’s immunotherapy combination of Opdivo and Yervoy. Naloxone can reverse Opioid overdose The U.S. FDA has recently approved Naloxone also known as Narcan- the first generic nasal spray to treat Opioid overdose. Narcan, developed by Israel’s Teva Pharmaceuticals, is a pre-filled, needle-free device which is sprayed into the nostrils of...
Explore More...